The Department of Health and Human Services (HHS) has stopped funding for a next-generation COVID-19 vaccine that received an award during the Biden administration, the company making the vaccine said on April 16.
Georgia-based Geovax said that the stop-work order from HHS went into effect on April 11 and affected an award of some $24.3 million from the Biomedical Advanced Research and Development Authority (BARDA), an HHS component that was placed in charge of the Biden administration’s Project NextGen.
